Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
61M
-
Shares change
-
+3.42M
-
Total reported value, excl. options
-
$1.45B
-
Value change
-
+$92.5M
-
Put/Call ratio
-
6.11
-
Number of buys
-
88
-
Number of sells
-
-78
-
Price
-
$23.77
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2014
201 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2014.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61M shares
of 115M outstanding shares and own 52.95% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.77M shares), VANGUARD GROUP INC (4.29M shares), OAK RIDGE INVESTMENTS LLC (2.66M shares), Bank of New York Mellon Corp (2.37M shares), Champlain Investment Partners, LLC (2.31M shares), KALMAR INVESTMENTS INC /DE/ (1.94M shares), BlackRock Fund Advisors (1.86M shares), BlackRock Institutional Trust Company, N.A. (1.69M shares), Invesco Ltd. (1.66M shares), and GANNETT WELSH & KOTLER (1.61M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.